Brief: Pharmasimple H1 2022 Revenue Of EUR 14.7 Mln

Pharmasimple SA

27/07/2022 17:07

July 27 (Reuters) - PHARMASIMPLE SA  ALPHS.PA :
    * H1 2022 REVENUE: EUR 14.7M
    * ANTICIPATES A RESUMPTION OF GROWTH IN THE 2ND HALF THANKS
TO THE
CONTRIBUTION OF TURNOVER FROM THE PHARMACIES ACQUIRED
    * INTENDS TO PURSUE ITS STRATEGY OF ACQUIRING PHARMACIES BY
THE
END OF THE YEAR IN ORDER TO EXCEED ITS INITIAL OBJECTIVE OF 15
PHARMACIES FOR 2022
    * WE ANTICIPATE THAT OFFLINE ACTIVITY WILL BE THE MAJORITY
OF THE
GROUP'S TOTAL TURNOVER FROM 2023

Source text for Eikon:  ID:nACT75748 
Further company coverage:  ALPHS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))